Funding for this research was provided by:
American Society of Clinical Oncology (Young Investigator Award)
Takeda Pharmaceuticals U.S.A. (Young Investigator Award)
University of Washington (SPORE in Pancreatic Cancer Career Enhancement Program)
Text and Data Mining valid from 2019-04-02
First Online: 2 April 2019
Compliance with Ethical Standards
: This work was funded by the NCI under award number K08CA238711 (A. A. Chaudhuri), a Cancer Research Foundation Young Investigator Award (A. A. Chaudhuri), the Washington University SPORE in Pancreatic Cancer Career Enhancement Program (A. A. Chaudhuri), and the Conquer Cancer Foundation ASCO Young Investigator Award (A. A. Chaudhuri), supported by Takeda Pharmaceuticals. Any opinions, findings and conclusions expressed in this material are those of the authors and do not necessarily reflect those of the American Society of Clinical OncologySuperscript removed, Conquer CancerSuperscript removed, or TakedaSuperscript removed.
: Aadel A. Chaudhuri has received speaker honoraria and travel support from Varian Medical Systems, Roche Sequencing Solutions, and Foundation Medicine, Inc., has research support from Roche Sequencing Solutions, has served as a consultant for Tempus Labs and for Oscar Health, and is a scientific advisor for Roche Sequencing Solutions and for Geneoscopy, LLC. Jonathan C. Dudley has served as a consultant for Merck. Re-I Chin, Kevin Chen, Abul Usmani, Chanelle Chua, Peter K. Harris, Michael S. Binkley, and Tej D. Azad declare that they have no conflicts of interest that might be relevant to the contents of this review.